Target intelligence / Profile preview

Colonic epithelial sodium and short-chain fatty acid (SCFA) transport pathways

Molecular classification
Transporter, Ion channel
01

Overview

Colonic epithelial sodium and short-chain fatty acid (SCFA) transport pathways are integrated systems responsible for maintaining fluid balance and providing energy to the colonic mucosa. Sodium absorption is primarily mediated by the epithelial sodium channel (ENaC) and the sodium-hydrogen exchanger 3 (NHE3), which are critical for water reabsorption and systemic blood pressure regulation (PubMed: 25644341). SCFAs, including butyrate and acetate, are transported via monocarboxylate transporters such as MCT1 and the sodium-coupled SMCT1 (SLC5A8) (UniProt: Q8N695). These pathways are functionally linked, as SCFA absorption often enhances sodium and water uptake, a process vital for preventing dehydration (PubMed: 16368716). Dysregulation of these transporters is a hallmark of inflammatory bowel diseases (IBD) and diarrheal disorders, where impaired absorption leads to electrolyte loss and mucosal damage (PubMed: 21903767). Pharmacological agents like tenapanor target NHE3 to treat irritable bowel syndrome, while ENaC inhibitors like amiloride are used for hypertension (StatPearls: NBK554444). Furthermore, therapeutic strategies often involve increasing SCFA availability to support colonocyte health and reduce inflammation in ulcerative colitis. Understanding these pathways is essential for developing targeted treatments for gastrointestinal and cardiovascular conditions.

Other names
Colonic electrolyte transportSCFA-sodium absorption systemMonocarboxylate transport systemColonic fluid homeostasis pathways
02

Mechanism of action

Modulation of ion and metabolite flux across the colonic epithelium to regulate fluid volume, maintain mucosal integrity, and provide metabolic fuel for colonocytes.

03

Biological functions

Electrolyte balanceNutrient absorptionpH regulationFluid homeostasisEnergy metabolism
04

Disease associations

DiarrheaInflammatory Bowel DiseaseUlcerative ColitisHypertensionIrritable Bowel Syndrome
05

Safety considerations

Electrolyte imbalanceHyperkalemiaMetabolic acidosisAltered gut microbiota compositionDehydration
06

Interacting drugs

Amiloride

4 more in the full profile.

07

Biomarkers

Fecal short-chain fatty acid levelsStool sodium concentrationMCT1 expressionNHE3 activityTransepithelial potential difference

Beyond the preview

Go deeper on Colonic epithelial sodium and short-chain fatty acid (SCFA) transport pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic epithelial sodium and short-chain fatty acid (SCFA) transport pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call